TM
RNAM

Torren Management’s Avidity Biosciences RNAM Stock Holding History

Torren Management’s Portfolio RNAM Stock Details RNAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-2,057
Closed -$148K – 1362
2025
Q4 		$148K Buy
+2,057
New +$133K 0.08% 92

Other funds holding RNAM

CC
Corsicana & Co Corsicana, Texas $158M AUM

Torren Management's RNAM Position: Q1 2026 in Review

Torren Management sold out of Avidity Biosciences (RNAM) in Q1 2026, closing a stake of 2,057 shares — an estimated $148K sold.

Torren Management first reported a position in RNAM in Q4 2025 and held it in 1 quarter. The position peaked at $148K in Q4 2025. 1 fund tracked by Wall St. Rank holds RNAM as of Q1 2026.

  • Torren Management reported no remaining Avidity Biosciences position as of Q1 2026 after selling out during the quarter.
  • Torren Management sold 2,057 Avidity Biosciences shares in Q1 2026, an estimated $148K.
  • Torren Management first reported a position in Avidity Biosciences in Q4 2025 and held it in 1 quarter.
  • Torren Management's Avidity Biosciences position peaked at $148K in Q4 2025.
  • 1 fund tracked by Wall St. Rank held Avidity Biosciences as of Q1 2026.

Based on Torren Management's 13F filing for Q1 2026, filed 30 Apr 2026.